6FIB

Structure of human 4-1BB ligand


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.70 Å
  • R-Value Free: 0.221 
  • R-Value Work: 0.166 
  • R-Value Observed: 0.169 

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy.

Claus, C.Ferrara, C.Xu, W.Sam, J.Lang, S.Uhlenbrock, F.Albrecht, R.Herter, S.Schlenker, R.Husser, T.Diggelmann, S.Challier, J.Mossner, E.Hosse, R.J.Hofer, T.Brunker, P.Joseph, C.Benz, J.Ringler, P.Stahlberg, H.Lauer, M.Perro, M.Chen, S.Kuttel, C.Bhavani Mohan, P.L.Nicolini, V.Birk, M.C.Ongaro, A.Prince, C.Gianotti, R.Dugan, G.Whitlow, C.T.Solingapuram Sai, K.K.Caudell, D.L.Burgos-Rodriguez, A.G.Cline, J.M.Hettich, M.Ceppi, M.Giusti, A.M.Crameri, F.Driessen, W.Morcos, P.N.Freimoser-Grundschober, A.Levitsky, V.Amann, M.Grau-Richards, S.von Hirschheydt, T.Tournaviti, S.Molhoj, M.Fauti, T.Heinzelmann-Schwarz, V.Teichgraber, V.Colombetti, S.Bacac, M.Zippelius, A.Klein, C.Umana, P.

(2019) Sci Transl Med 11

  • DOI: 10.1126/scitranslmed.aav5989
  • Primary Citation of Related Structures:  
    6FIB

  • PubMed Abstract: 
  • Endogenous costimulatory molecules on T cells such as 4-1BB (CD137) can be leveraged for cancer immunotherapy. Systemic administration of agonistic anti-4-1BB antibodies, although effective preclinically, has not advanced to phase 3 trials because they have been hampered by both dependency on Fcγ receptor-mediated hyperclustering and hepatotoxicity ...

    Endogenous costimulatory molecules on T cells such as 4-1BB (CD137) can be leveraged for cancer immunotherapy. Systemic administration of agonistic anti-4-1BB antibodies, although effective preclinically, has not advanced to phase 3 trials because they have been hampered by both dependency on Fcγ receptor-mediated hyperclustering and hepatotoxicity. To overcome these issues, we engineered proteins simultaneously targeting 4-1BB and a tumor stroma or tumor antigen: FAP-4-1BBL (RG7826) and CD19-4-1BBL. In the presence of a T cell receptor signal, they provide potent T cell costimulation strictly dependent on tumor antigen-mediated hyperclustering without systemic activation by FcγR binding. We could show targeting of FAP-4-1BBL to FAP-expressing tumor stroma and lymph nodes in a colorectal cancer-bearing rhesus monkey. Combination of FAP-4-1BBL with tumor antigen-targeted T cell bispecific (TCB) molecules in human tumor samples led to increased IFN-γ and granzyme B secretion. Further, combination of FAP- or CD19-4-1BBL with CEA-TCB (RG7802) or CD20-TCB (RG6026), respectively, resulted in tumor remission in mouse models, accompanied by intratumoral accumulation of activated effector CD8 + T cells. FAP- and CD19-4-1BBL thus represent an off-the-shelf combination immunotherapy without requiring genetic modification of effector cells for the treatment of solid and hematological malignancies.


    Organizational Affiliation

    Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Wagistrasse 10, 8952 Schlieren, Switzerland. pablo.umana@roche.com.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Tumor necrosis factor ligand superfamily member 9 A188Homo sapiensMutation(s): 0 
Gene Names: TNFSF9
Find proteins for P41273 (Homo sapiens)
Explore P41273 
Go to UniProtKB:  P41273
NIH Common Fund Data Resources
PHAROS:  P41273
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetailsImage
Tumor necrosis factor ligand superfamily member 9,4-1BBL -CH/CL fusion B311Homo sapiensMutation(s): 0 
Gene Names: TNFSF9
Find proteins for P41273 (Homo sapiens)
Explore P41273 
Go to UniProtKB:  P41273
NIH Common Fund Data Resources
PHAROS:  P41273
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 3
MoleculeChainsSequence LengthOrganismDetailsImage
Tumor necrosis factor ligand superfamily member 9,Uncharacterized protein C292Homo sapiensMutation(s): 0 
Gene Names: TNFSF9
Find proteins for P41273 (Homo sapiens)
Explore P41273 
Go to UniProtKB:  P41273
NIH Common Fund Data Resources
PHAROS:  P41273
Protein Feature View
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.70 Å
  • R-Value Free: 0.221 
  • R-Value Work: 0.166 
  • R-Value Observed: 0.169 
  • Space Group: P 62
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 119.592α = 90
b = 119.592β = 90
c = 104.35γ = 120
Software Package:
Software NamePurpose
BUSTERrefinement
XDSdata reduction
SADABSdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2019-03-13
    Type: Initial release
  • Version 1.1: 2019-06-26
    Changes: Data collection, Database references